ISR Reports study finds SGS Life Sciences a stand-out Phase I service provider

Informing the drug development and commercialization industry Cary, N.C. – June 11, 2014 – Industry Standard Research (ISR) today announced the release of their “CRO Quality Benchmarking – Phase I Service Providers” report.  This research, based on in-depth surveys collected from 113 pharmaceutical Phase I decision-makers, indicates that SGS Life Sciences out-performs customers’ expectations across … Continued

New ISR Report Provides Insight into Bladder Cancer Market, Clinical Pipeline

Informing the pharmaceutical drug development and commercialization industry Cary, N.C. – April 15, 2014 – Industry Standard Research (ISR) is announcing the release of its latest report entitled “Bladder Cancer: Disease and Pipeline Analysis.”  This report provides an overview of the current and future bladder cancer clinical development market, the activities of the key market … Continued

DCRI Receives Top Customer Loyalty Scores in ISR’s 6th Annual CRO Quality Benchmarking Study

Informing the Pharmaceutical Drug Development and Commercialization Industry. Cary, N.C. – March 19, 2014 – Industry Standard Research (ISR) is announcing the launch of its 6th annual CRO Quality Benchmarking series with today’s release of its “CRO Quality Benchmarking – Phase II/III Service Providers (2014)” report. This report provides a Consumer Reports-style analysis of CRO quality with respondents … Continued

New ISR Report Provides Insight into CMO Service Quality, DSM among the Top 3 in Each Attribute Category

Informing the pharmaceutical drug development and commercialization industry. Cary, N.C. – March 12, 2014 – Industry Standard Research (ISR) today announced the availability of a new report titled “Contract Manufacturer Quality Benchmarking (2014),” providing a comprehensive assessment of CMO service quality. “ISR has a long history of measuring service provider quality across the clinical development … Continued

ISR Identifies Patterns of Unmet Needs amongst US Patients Suffering from Headaches

Informing the pharmaceutical drug development and commercialization industry. Cary, N.C. – March 5, 2013 – Industry Standard Research (ISR) has announced the release of a new market research report titled “Headaches: Current Treatments, Unmet Needs, and Patient Recruitment.” This report surveyed 209 US-based patients who suffer from chronic cluster headaches, tension headaches, or migraines to … Continued

New ISR Report Identifies why Forest Labs’ Pipeline is a Hot Topic

Informing the pharmaceutical drug development and commercialization industry. Cary, N.C. – February 25, 2014 – Industry Standard Research (ISR) has announced the availability of a new report titled “Forest Labs Clinical Development Profile.”  This report provides a thorough analysis of Forest Laboratories’ R&D pipeline, clinical trial activity, patents, FDA submissions, and includes profiles of Forest’s … Continued

New ISR Report Uncovers Significant Clinical Development Activity, Opportunity in Brazilian Market

Informing the pharmaceutical drug development and commercialization industry. Cary, N.C. – February 20, 2014 – Industry Standard Research (ISR) released a new market research report this week entitled “Brazil: Clinical Development Country Profile.” The report provides insight into the clinical trial environment in Brazil, sponsor and service provider activities in the region, as well as the Brazilian … Continued

ISR’s Brain Cancer (Glioblastoma Multiforme) Report Analyzes Market Opportunity, Product Pipelines

Informing the pharmaceutical drug development and commercialization industry. Cary, N.C. – February 19, 2013 – Industry Standard Research (ISR) today announced the release of a new market research report titled “Brain Cancer (Glioblastoma Multiforme): Disease and Pipeline Analysis,” offering the biopharmaceutical industry an in-depth overview of the current glioblastoma multiforme (GBM) market and an analysis … Continued

ISR Projects the 2014 CRO Market to be Worth $23.6 Billion

Informing the pharmaceutical drug development and commercialization industry. Cary, N.C. – February 4, 2014 – Industry Standard Research (ISR) has announced the availability of a new report titled “2014 CRO Market Size Projections: 2012-2018.”  For this report, ISR has utilized both publically available information and data obtained through their syndicated primary market research to provide … Continued

CRO Market Size: Growth in a Flat R&D World

ISR’s reports have been featured in numerous industry publications and news sources over the years. Below is a link to Appliedclinicaltrialsonline.com’s: CRO Market Size: Growth in a Flat R&D World https://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Blogs/CRO-Market-Size-Growth-in-a-Flat-RampD-World/ArticleStandard/Article/detail/834426

ISR Identifies Patterns of Unmet Needs amongst Autoimmune Disease Patients

Informing the pharmaceutical drug development and commercialization industry. Cary, N.C. – January 7, 2013 – Industry Standard Research (ISR) has announced the release of a new market research report entitled “Autoimmune Diseases: Current Treatments, Unmet Needs, and Patient Recruitment.” This report surveyed 208 US-based patients with an autoimmune disease to identify patterns and preferences surrounding … Continued

United Biosource Corporation (UBC) Receives High Marks for Staff Quality According to ISR Report

Informing the pharmaceutical drug development and commercialization industry. Cary, N.C. – January 6, 2013 – Industry Standard Research (ISR) has announced the availability of a new report titled “2013 CRO Quality Benchmarking – Phase IV Service Providers.”  This study surveyed 106 pharmaceutical and biotechnology professionals about their experiences with 27 small, mid-size, and large Phase … Continued

ISR CUSTOMERS